Question

In: Statistics and Probability

Eighteen middle-aged women with platelet readings between 120,000 platelets per microliter and 150,000 platelets per microliter...

Eighteen middle-aged women with platelet readings between 120,000 platelets per microliter and 150,000 platelets per microliter of blood were selected randomly from the population of similar female patients at a large local hospital. Nine of the 18 women were assigned randomly to group A and received a placebo. The other nine women were assigned to group B and received a new platelet drug. After four months, posttreatment platelet readings were taken for all 18 women and were compared with pretreatment readings. The reduction in platelet level (Pretreatment reading − Posttreatment reading) for each woman in the study is shown here.

Group A (placebo) increase (in platelets per microliter): 2,000, 5,000, 7,050, 10,125, 12,345, 17,350, 13,250, 12,200, 9,125

Group B (platelet drug) increase (platelets per microliter): 28,450, 23,438, 36,380, 12,450, 16,100, 21,350, 39,400, 41,000, 14,325

Part A: Do the data provide convincing evidence, at the α = 0.05 level, that the platelet drug is effective in producing a reduction in mean platelet level? (6 points)

Part B: Create and interpret a 95% confidence interval for the difference in the placebo and the new drug. (4 points)

Solutions

Expert Solution

Answer:-

Given that:-

Eighteen middle-aged women with platelet readings between 120,000 platelets per microliter and 150,000 platelets per microliter of blood were selected randomly from the population of similar female patients at a large local hospital. Nine of the 18 women were assigned randomly to group A and received a placebo. The other nine women were assigned to group B and received a new platelet drug. After four months, posttreatment platelet readings were taken for all 18 women and were compared with pretreatment readings. The reduction in platelet level (Pretreatment reading − Posttreatment reading) for each woman in the study is shown here.

Group A (placebo) increase (in platelets per microliter): 2,000, 5,000, 7,050, 10,125, 12,345, 17,350, 13,250, 12,200, 9,125

Group B (platelet drug) increase (platelets per microliter): 28,450, 23,438, 36,380, 12,450, 16,100, 21,350, 39,400, 41,000, 14,325

Here from the samples

       

There is no.difference in placebo & plates drug

The platelet drug is effecticve.

  

Test statistic

  

Critical value at 5% L.O.S is -1.746

P-value =0.05, Given

Here P-value<0.05, so reject

Hence there is a sufficient evidence that the platelet drug is effective.

B) At 95% confidence for 16 d.f

The 95% confidence intervals are


Related Solutions

Pauline - Pauline is a middle aged, obese women. She recently began having severe soreness in...
Pauline - Pauline is a middle aged, obese women. She recently began having severe soreness in her abdomen and a lot of nausea. Pauline visited a specialist and the Doctor is leaning towards the diagnosis of pancreatitis due to a blockage. Pauline also happens to consume a diet that is low in protein and high in fat content. Diagram and/or explain the anatomy of where the blockage would occur leading to pancreatitis. What is causing the blockage specifically and why?...
A researcher is interested in studying the effect that the amount of fat in the diet and amount of exercise has on the mental acuity of middle-aged women
A researcher is interested in studying the effect that the amount of fat in the diet and amount of exercise has on the mental acuity of middle-aged women. The researcher used three different treatment levels for the diet and two levels for the exercise. The results of the acuity test for the subjects in the different treatment levels are shown below.DietExercise<30% fat30% - 60% fat>60% fat<60 minutes43241222242233160 minutes685or more587475485566Perform a Two-way analysis of variance (ANOVA) and report the results using...
Literature shows that the incidence of breast cancer is 150 cases per 100,000 women aged 45-49...
Literature shows that the incidence of breast cancer is 150 cases per 100,000 women aged 45-49 years old annually. The researchers want to test whether regular intake of vitamin D would reduce 20% of the risk of the occurence of breast cancer. They plan to recruit women aged 45-49 years who are free of breast cancer at the beginning and randomly assign them into two groups, i.e., group one: women in this group will receive vitamin D treatment, and group...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT